|
|
| Divis Laboratories Limited |
|
Financials-Divis Laboratories Limited| Sector: Pharmaceuticals - Others | | BSE:532488 | NSE:DIVISLAB | Bloomberg:DIVI@IN | Reuters:DIVI.BO | | Market Lot: 1 | Face Value: 2 | ISIN Demat: INE361B01024 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
30-Sep-2020(3) |
30-Sep-2019(3) |
% Change |
| Sales of Products/Services |
17137.80 |
14039.20 |
22.07 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
136.40 |
473.60 |
-71.20 |
| Total Income |
17274.20 |
14512.80 |
19.03 |
| Total Expenses |
-10423.90 |
-9682.60 |
7.66 |
| OPBDIT |
27698.10 |
24195.40 |
14.48 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-608.90 |
-9682.60 |
-93.71 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-1717.30 |
-1301.90 |
31.91 |
| After Tax Profit |
5133.00 |
3528.30 |
45.48 |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
7254.08 |
98.09 |
3811.11 |
97.29 |
3475.34 |
95.36 |
| Operating Income (OI) |
7395.36 |
100.00 |
3917.36 |
100.00 |
3644.61 |
100.00 |
| OPBDIT |
2611.65 |
35.31 |
1288.51 |
32.89 |
1215.35 |
33.35 |
| OPBDT |
2490.32 |
33.67 |
1217.27 |
31.07 |
1174.34 |
32.22 |
| OPBT |
2267.04 |
30.65 |
1069.11 |
27.29 |
1023.67 |
28.09 |
| Non-Operating Income |
0.00 |
0.00 |
0.00 |
0.00 |
-0.53 |
-0.01 |
| Extraordinary/Prior Period |
-13.67 |
-0.18 |
-31.32 |
-0.80 |
-27.45 |
-0.75 |
| Tax |
335.91 |
4.54 |
333.08 |
8.50 |
335.38 |
9.20 |
| Profit after tax(PAT) |
1917.45 |
25.93 |
704.71 |
17.99 |
660.31 |
18.12 |
| Cash Profit |
2140.74 |
28.95 |
852.87 |
21.77 |
810.98 |
22.25 |
| Dividend-Equity |
129.11 |
1.75 |
128.19 |
3.27 |
102.55 |
2.81 |
|
| As on |
31-Mar-07 |
|
31-Mar-06 |
|
31-Mar-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
4906.66 |
57.63 |
3018.56 |
46.43 |
2538.05 |
55.87 |
| Net Block |
3811.92 |
44.77 |
2147.74 |
33.04 |
1815.44 |
39.96 |
| Capital WIP |
382.47 |
4.49 |
802.73 |
12.35 |
10.88 |
0.24 |
| Investments |
5.84 |
0.07 |
3.98 |
0.06 |
0.00 |
0.00 |
| Inventory |
2100.46 |
24.67 |
1838.59 |
28.28 |
1390.49 |
30.61 |
| Receivables |
1644.61 |
19.32 |
1074.42 |
16.53 |
1021.69 |
22.49 |
| Other Current Assets |
568.72 |
6.68 |
633.34 |
9.74 |
304.47 |
6.70 |
| Balance Sheet Total(BT) |
8514.02 |
100.00 |
6500.80 |
100.00 |
4542.97 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
129.11 |
1.52 |
128.19 |
1.97 |
128.19 |
2.82 |
| Reserves |
5291.34 |
62.15 |
3279.98 |
50.46 |
2708.41 |
59.62 |
| Total Debt |
1539.56 |
18.08 |
1501.80 |
23.10 |
660.90 |
14.55 |
| Creditors and Acceptances |
1014.83 |
11.92 |
839.30 |
12.91 |
554.50 |
12.21 |
| Other current liab/prov. |
539.18 |
6.33 |
751.53 |
11.56 |
490.98 |
10.81 |
| Balance Sheet Total(BT) |
8514.02 |
100.00 |
6500.80 |
100.00 |
4542.97 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
36.34 |
27.79 |
30.54 |
| PBIT/Cap. Employed (%) |
36.10 |
27.00 |
29.73 |
| PAT/Networth (%) |
35.37 |
20.68 |
23.28 |
| Tax/PBT (%) |
14.91 |
32.10 |
33.68 |
| Total Debt/Networth (x) |
0.28 |
0.44 |
0.23 |
| Long Term Debt/Networth (x) |
0.17 |
0.18 |
0.01 |
| PBDIT/Finance Charges (x) |
21.41 |
17.65 |
28.95 |
| Current Ratio (x) |
2.78 |
2.23 |
2.60 |
| RM Inventory (days consumption) |
199.92 |
330.11 |
236.05 |
| FG inventory (days cost of sales) |
22.89 |
18.93 |
23.06 |
| Receivables (days gross sales) |
82.26 |
101.70 |
106.16 |
| Creditors (days cost of sales) |
77.43 |
116.53 |
83.31 |
| Op. curr. assets (days OI) |
213.00 |
330.00 |
272.00 |
|
|
Financials